Sub-Total: $0.00
Faecal Microbiota Transplantation as Primary Treatment for Clostridioidoes difficile Infection-evidence for Change
$0.00
Related products
-
The Microbiome and the Heart
$0.00 Add to cart -
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer
$0.00 Add to cart -
Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation: a case report
$0.00 Add to cart -
S227 Messenger RNA SARS-CoV-2 Vaccines Affect the Gut Microbiome
$0.00 Add to cart